Key facts
- This page summarizes John C. Jacobs's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Aug 2022, 16:04.
John C. Jacobs - 15 Aug 2022 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)
- Reporting relationship
- PRESIDENT, CEO, Director
- Issuer ticker
- HRMY
- Reported as of
- 15 Aug 2022
- Net transaction value
- -$1,714,013
- SEC form
- 4
- Accepted by SEC
- 16 Aug 2022, 16:04:29 UTC
- Prior SEC filing
- 16 Jun 2022
- Next SEC filing
- 25 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Ulrich, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John C. Jacobs filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 16 Aug 2022.
Change
- Previous filing in this sequence was filed on 16 Jun 2022.
- Current net transaction value: -$1,714,013.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HRMY
transaction
Common Stock
Options Exercise
- Transaction value
- $328,800
- Shares
- +40,000
- Change %
- Price
- $8.22*
- Shares after
- 40,000
- Date
- 15 Aug 2022
- Ownership
- Direct
HRMY
transaction
Common Stock
Sale
- Transaction value
- $1,995,760
- Shares
- -39,091
- Change %
- -98%
- Price
- $51.05
- Shares after
- 909
- Date
- 15 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F2
HRMY
transaction
Common Stock
Sale
- Transaction value
- $47,053
- Shares
- -909
- Change %
- -100%
- Price
- $51.76
- Shares after
- 0
- Date
- 15 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HRMY
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -40,000
- Change %
- -26%
- Price
- $0.000000
- Shares after
- 114,751
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $8.22
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.56 to $51.54. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.56 to $52.05. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The stock option vests in five equal annual installments beginning on October 1, 2018.